acetazolamide

Generic: acetazolamide

Labeler: trupharma, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acetazolamide
Generic Name acetazolamide
Labeler trupharma, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

acetazolamide 250 mg/1

Manufacturer
TRUPHARMA, LLC

Identifiers & Regulatory

Product NDC 52817-201
Product ID 52817-201_1df8bd81-54fe-44ea-98aa-5f13592dd8bd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211372
Listing Expiration 2026-12-31
Marketing Start 2021-04-19

Pharmacologic Class

Established (EPC)
carbonic anhydrase inhibitor [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa]
Chemical Structure
sulfonamides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 52817201
Hyphenated Format 52817-201

Supplemental Identifiers

RxCUI
197303 197304
UPC
0352817200105
UNII
O3FX965V0I
NUI
N0000175517 N0000000235 M0020790

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetazolamide (source: ndc)
Generic Name acetazolamide (source: ndc)
Application Number ANDA211372 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE, PLASTIC (52817-201-00)
  • 100 TABLET in 1 BOTTLE, PLASTIC (52817-201-10)
source: ndc

Packages (2)

Ingredients (1)

acetazolamide (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1df8bd81-54fe-44ea-98aa-5f13592dd8bd", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "upc": ["0352817200105"], "unii": ["O3FX965V0I"], "rxcui": ["197303", "197304"], "spl_set_id": ["4fcd428a-7bf3-4e75-a834-1bdf1078107f"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["TRUPHARMA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE, PLASTIC (52817-201-00)", "package_ndc": "52817-201-00", "marketing_start_date": "20210601"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE, PLASTIC (52817-201-10)", "package_ndc": "52817-201-10", "marketing_start_date": "20210601"}], "brand_name": "ACETAZOLAMIDE", "product_id": "52817-201_1df8bd81-54fe-44ea-98aa-5f13592dd8bd", "dosage_form": "TABLET", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "52817-201", "generic_name": "ACETAZOLAMIDE", "labeler_name": "TRUPHARMA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ACETAZOLAMIDE", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "250 mg/1"}], "application_number": "ANDA211372", "marketing_category": "ANDA", "marketing_start_date": "20210419", "listing_expiration_date": "20261231"}